Condition: Ischemic Stroke · TIA · Sponsor: Beijing Tiantan Hospital
This study is a multicentre, randomized, double-blind, placebo-controlled, investigator-sponsored study that aims to investigate the efficacy of colchicine in preventing recurrent stroke in the patients with acute minor-to-moderate ischemic stroke or TIA and a hsCRP level of ≥2mg/L.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Linquan County People's Hospital | Fuyang, Anhui, China | — |
| Huangshan City People's Hospital | Huangshan City, Anhui, China | — |
| The First Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | — |
| The First People's Hospital of Wuhu | Wuhu, Anhui, China | — |
| Beijing Tiantan Hospital, Capital Medical University | Beijing, Beijing Municipality, China | — |
| Beijing Shunyi Airport Hospital | Beijing, Beijing Municipality, China | — |
| Beijing Shunyi Hospital | Beijing, Beijing Municipality, China | — |
| Fuxing Hospital, Capital Medical University | Beijing, Beijing Municipality, China | — |
| The First Hospital of Fangshan District, Beijing | Beijing, Beijing Municipality, China | — |
| Chongqing Sanbo Chang 'an Hospital | Chongqing, Chongqing Municipality, China | — |
| Chongqing Tungwah Hospital | Chongqing, Chongqing Municipality, China | — |
| Chongqing University Fuling Hospital | Chongqing, Chongqing Municipality, China | — |
+ 232 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.